0.00
price down icon100.00%   -1.71
after-market Handel nachbörslich: 2.16 2.16 +
loading

Finanzdaten der Aptose Biosciences Inc-Aktie (APTO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
19.52%
9.76
12.13 11.68 14.45 14.10
Nonoperating Income/Loss
30.23%
0.12
0.172 0.234 0.323 0.42
Income/Loss From Continuing Operations Before Tax
104.18%
0.50
-11.96 -11.45 -14.13 -13.68
Income/Loss From Continuing Operations After Tax
104.18%
0.50
-11.96 -11.45 -14.13 -13.68
Net Income/Loss
19.36%
-9.64
-11.96 -11.45 -14.13 -13.68
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,508%
13.13
0.364 6.495 6.234 92.56
Diluted Average Shares
3,508%
13.13
0.364 6.495 6.234 92.56
Basic Earnings Per Share
53.50%
-0.73
-1.57 -1.76 -2.27 -2.25
Diluted Earnings Per Share
53.50%
-0.73
-1.57 -1.76 -2.27 -2.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):